1. Home
  2. GSBD vs CRON Comparison

GSBD vs CRON Comparison

Compare GSBD & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSBD

Goldman Sachs BDC Inc.

HOLD

Current Price

$8.89

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Cronos Group Inc.

CRON

Cronos Group Inc.

HOLD

Current Price

$2.71

Market Cap

985.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSBD
CRON
Founded
2012
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
985.8M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
GSBD
CRON
Price
$8.89
$2.71
Analyst Decision
Sell
Analyst Count
2
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
1.4M
1.6M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
13.49%
N/A
EPS Growth
87.27
N/A
EPS
N/A
0.04
Revenue
N/A
$146,587,000.00
Revenue This Year
N/A
$26.34
Revenue Next Year
N/A
$15.53
P/E Ratio
N/A
$68.38
Revenue Growth
N/A
24.63
52 Week Low
$8.65
$1.84
52 Week High
$12.03
$3.43

Technical Indicators

Market Signals
Indicator
GSBD
CRON
Relative Strength Index (RSI) 37.39 53.81
Support Level N/A $2.47
Resistance Level $10.13 $2.72
Average True Range (ATR) 0.22 0.10
MACD -0.08 0.00
Stochastic Oscillator 14.71 39.23

Price Performance

Historical Comparison
GSBD
CRON

About GSBD Goldman Sachs BDC Inc.

Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.

About CRON Cronos Group Inc.

Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.

Share on Social Networks: